You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, look for clinical trials, and connect with others living with it — all in one place.
Open the full Hereditary thrombocytopenia and hematologic cancer predisposition syndrome hub →Hereditary thrombocytopenia and hematologic cancer predisposition syndrome is a rare condition. Also known as FPD/AML, FPDMM, FPS/AML, Familial platelet disorder with predisposition to acute myelogenous leukemia, Familial platelet disorder with predisposition to myeloid malignancy, Familial platelet disorder with propensity to acute myeloid leukemia, Familial thrombocytopenia with propensity to acute myelogenous leukemia, RUNX1 familial platelet disorder. Tomeko brings together the specialists, research, clinical trials, treatments and community for Hereditary thrombocytopenia and hematologic cancer predisposition syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:71290 · OMIM 601399 · ICD-10 D69.1 · GARD 0010352
Start by learning the basics from an authoritative source, find a specialist or center that sees Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, filtered to your area.
Tomeko shows live, recruiting studies for Hereditary thrombocytopenia and hematologic cancer predisposition syndrome from ClinicalTrials.gov on the hub.